RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $16 | $51 | $48 |
| - Cash | $1 | $1 | $2 | $2 |
| + Debt | $3 | $1 | $0 | $0 |
| Enterprise Value | $8 | $16 | $49 | $47 |
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| EBITDA | -$1 | -$1 | -$1 | $0 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |
| Net Income | -$1 | -$2 | -$1 | $0 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| Operating Cash Flow | -$1 | -$2 | -$1 | $0 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$0 |